Lexaria Bioscience Corp. — Director's Dealing 2019

Dec 30, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Lexaria Bioscience Corp. (LXRP)
CIK: 0001348362
Period of Report: 2019-12-30

Reporting Person: DOCHERTY JOHN MARTIN (Director, President)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-12-30	Stock Options	$0.09	J	550000	Acquired	2020-03-26	Common Shares (550000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
common shares	1622250	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Options	$0.09	2020-03-26	Common Shares (550000)	550000	Direct
Stock Options	$0.11	2021-04-15	Common Shares (300000)	850000	Direct
Stock Options	$1.53	2023-05-31	Common Shares (400000)	1250000	Direct

Footnotes

F1: Cancellation of Options